GSE39316-HMDM

Platform: Illumina Sentrix HumanHT-12 Expression BeadChips, version 3

Organism: Homo sapiens

Pdf version of the dendrogram

Set title:

Nanotoxicogenomic study of ZnO and TiO2 responses

Citation:

Tuomela S, Autio R, Buerki-Thurnherr T, Arslan O et al. Gene expression profiling of immune-competent human cells exposed to engineered zinc oxide or titanium dioxide nanoparticles. PLoS One. 2013 Jul 22;8(7):e68415.

Set summary:

A comprehensive in vitro assessment of two commercial metal oxide nanoparticles, TiO2 and ZnO, was performed using human monocyte-derived macrophages (HMDM), monocyte-derived dendritic cells (MDDC), and T cell leukemia-derived cell line (Jurkat). TiO2 nanoparticles were found to be non-toxic whereas ZnO nanoparticles caused dose-dependent cell death. Subsequently, global gene expression profiling was performed to identify signaling pathways underlying the cytotoxicity caused by ZnO nanoparticles. Analysis was done with doses, 1µg/ml and 10µg/ml after 6 and 24 hours of exposure. Interestingly, 2703 genes were significantly differentially expressed in HMDM upon exposure to 10µg/ml ZnO nanoparticles, while in MDDCs only 12 genes were affected. In Jurkat cells, 980 genes were differentially expressed. It is noteworthy that the gene expression of metallothioneins was upregulated in all the three cell types. In addition to the common ZnO-inducible changes, a notable proportion of the genes were regulated in a cell type-specific manner. Using a panel of ZnO nanoparticles, we obtained an additional support that the cellular response to ZnO nanoparticles is caused by particle dissolution. Gene ontology analysis revealed that the top biological processes disturbed in HMDM and Jurkat cells were regulating cell death and growth. In addition, genes controlling immune system development were affected. Bioinformatics assessment showed that the top human disease category associated with ZnO-responsive genes in both HMDM and Jurkat cells was cancer. Overall, the study revealed novel genes and pathways for mediating ZnO nanoparticle-induced toxicity and demonstrated the value of assessing nanoparticle responses through combined transcriptomics and bioinformatics approach.


Sample_name Description Type Treatment Dose NP_size
GSM960797 HMDC_rep1_ctr_6h_0 HMDM no treatment - -
GSM960807 HMDC_rep2_ctr_6h_0 HMDM no treatment - -
GSM960817 HMDC_rep3_ctr_6h_0 HMDM no treatment - -
GSM960799 HMDC_rep1_TiO2_6h_1 HMDM TiO2 1µg/ml 21nm
GSM960809 HMDC_rep2_TiO2_6h_1 HMDM TiO2 1µg/ml 21nm
GSM960819 HMDC_rep3_TiO2_6h_1 HMDM TiO2 1µg/ml 21nm
GSM960800 HMDC_rep1_TiO2_6h_10 HMDM TiO2 10µg/ml 21nm
GSM960810 HMDC_rep2_TiO2_6h_10 HMDM TiO2 10µg/ml 21nm
GSM960820 HMDC_rep3_TiO2_6h_10 HMDM TiO2 10µg/ml 21nm
GSM960803 HMDC_rep1_ZnO_6h_1 HMDM ZnO 1µg/ml 10 ± 2nm
GSM960813 HMDC_rep2_ZnO_6h_1 HMDM ZnO 1µg/ml 10 ± 2nm
GSM960823 HMDC_rep3_ZnO_6h_1 HMDM ZnO 1µg/ml 10 ± 2nm
GSM960804 HMDC_rep1_ZnO_6h_10 HMDM ZnO 10µg/ml 10 ± 2nm
GSM960814 HMDC_rep2_ZnO_6h_10 HMDM ZnO 10µg/ml 10 ± 2nm
GSM960824 HMDC_rep3_ZnO_6h_10 HMDM ZnO 10µg/ml 10 ± 2nm
GSM960798 HMDC_rep1_ctr_24h_0 HMDM no treatment - -
GSM960808 HMDC_rep2_ctr_24h_0 HMDM no treatment - -
GSM960818 HMDC_rep3_ctr_24h_0 HMDM no treatment - -
GSM960801 HMDC_rep1_TiO2_24h_1 HMDM TiO2 1µg/ml 21nm
GSM960811 HMDC_rep2_TiO2_24h_1 HMDM TiO2 1µg/ml 21nm
GSM960821 HMDC_rep3_TiO2_24h_1 HMDM TiO2 1µg/ml 21nm
GSM960802 HMDC_rep1_TiO2_24h_10 HMDM TiO2 10µg/ml 21nm
GSM960812 HMDC_rep2_TiO2_24h_10 HMDM TiO2 10µg/ml 21nm
GSM960822 HMDC_rep3_TiO2_24h_10 HMDM TiO2 10µg/ml 21nm
GSM960805 HMDC_rep1_ZnO_24h_1 HMDM ZnO 1µg/ml 10 ± 2nm
GSM960815 HMDC_rep2_ZnO_24h_1 HMDM ZnO 1µg/ml 10 ± 2nm
GSM960825 HMDC_rep3_ZnO_24h_1 HMDM ZnO 1µg/ml 10 ± 2nm
GSM960806 HMDC_rep1_ZnO_24h_10 HMDM ZnO 10µg/ml 10 ± 2nm
GSM960816 HMDC_rep2_ZnO_24h_10 HMDM ZnO 10µg/ml 10 ± 2nm
GSM960826 HMDC_rep3_ZnO_24h_10 HMDM ZnO 10µg/ml 10 ± 2nm

<<back